Background The infectious coronavirus disease 2019 (COVID-19) pandemic is an ongoing
global healthcare challenge. Up to one-third of hospitalised patients develop severe …

The long-term respiratory morbidity of COVID-19 remains unclear. We describe the clinical,
radiological and pulmonary function abnormalities that persist in previously hospitalised …

Introduction Prospective and longitudinal data on pulmonary injury over one year after acute
coronavirus disease 2019 (COVID-19) are sparse. We aim to determine reductions in …

Background: Long-term pulmonary sequelae following severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia are not yet confirmed; however, preliminary …

Background More than 20% of hospitalized patients with COVID-19 demonstrate ARDS
requiring ICU admission. The long-term respiratory sequelae in such patients remain …

Background The coronavirus disease (COVID-19) pandemic has already affected more than
400 million people, with increasing numbers of survivors. These data indicate that a myriad …

Background After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of
survivors exhibited persisting structural pulmonary abnormalities. The long-term pulmonary …

Background Long-term pulmonary sequelae following hospitalization for SARS-CoV-2
pneumonia is largely unclear. The aim of this study was to identify and characterise …

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown.
We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest …

Background COVID-19 pandemic resulted in an unprecedented number of hospitalizations
in general wards and intensive care units (ICU). Severe and critical COVID-19 patients suffer …